Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 212 items for :

  • "Graves disease" x
Clear All
Tereza Planck Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
Department of Endocrinology, Skåne University Hospital, Malmö, Sweden

Search for other papers by Tereza Planck in
Google Scholar
PubMed Close
,
Bushra Shahida Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden

Search for other papers by Bushra Shahida in
Google Scholar
PubMed Close
,
Johan Malm Department of Translational Medicine, Section for Clinical Chemistry, Lund University, Malmö, Sweden

Search for other papers by Johan Malm in
Google Scholar
PubMed Close
, and
Jonas Manjer Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden
Department of Surgery, Skåne University Hospital, Malmö, Sweden

Search for other papers by Jonas Manjer in
Google Scholar
PubMed Close

involved in vitamin D metabolism has been associated with several autoimmune disorders including autoimmune thyroid disease [ 2 - 7 ]. Several studies suggest that individuals with Graves disease (GD) have lower vitamin D levels than the general population

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000484521
Volume/Issue:
Volume 7: Issue 1
Free access
Anke Schlüter Molecular Ophthalmology, Department of Ophthalmology, University Hospital Essen, Essen, Germany
Department of Oto-Rhino-Laryngology – Head and Neck Surgery, University Hospital Essen, Essen, Germany

Search for other papers by Anke Schlüter in
Google Scholar
PubMed Close
,
Anja K. Eckstein Molecular Ophthalmology, Department of Ophthalmology, University Hospital Essen, Essen, Germany
Department of Ophthalmology, University Hospital Essen, Essen, Germany

Search for other papers by Anja K. Eckstein in
Google Scholar
PubMed Close
,
Alexandra Brenzel Imaging Center Essen (IMCES), Institute for Experimental Immunology and Imaging, University Hospital Essen, Essen, Germany

Search for other papers by Alexandra Brenzel in
Google Scholar
PubMed Close
,
Mareike Horstmann Molecular Ophthalmology, Department of Ophthalmology, University Hospital Essen, Essen, Germany

Search for other papers by Mareike Horstmann in
Google Scholar
PubMed Close
,
Stephan Lang Department of Oto-Rhino-Laryngology – Head and Neck Surgery, University Hospital Essen, Essen, Germany

Search for other papers by Stephan Lang in
Google Scholar
PubMed Close
,
Utta Berchner-Pfannschmidt Molecular Ophthalmology, Department of Ophthalmology, University Hospital Essen, Essen, Germany

Search for other papers by Utta Berchner-Pfannschmidt in
Google Scholar
PubMed Close
,
J. Paul Banga Molecular Ophthalmology, Department of Ophthalmology, University Hospital Essen, Essen, Germany

Search for other papers by J. Paul Banga in
Google Scholar
PubMed Close
, and
Salvador Diaz-Cano Department of Histopathology, King’s College Hospital NHS, London, United Kingdom

Search for other papers by Salvador Diaz-Cano in
Google Scholar
PubMed Close

Introduction Graves disease (GD) is caused by autoantibodies that induce hyperthyroidism by mimicking the action of TSH and activating the TSH receptor (TSHR). The defining component of hyperthyroidism is thyroid follicular hyperplasia

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000488079
Volume/Issue:
Volume 7: Issue 3
Free access
Mats Holmberg ANOVA, Karolinska University Hospital, Norra Stationsgatan 69, Stockholm, Sweden
Institute of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden

Search for other papers by Mats Holmberg in
Google Scholar
PubMed Close
,
Helge Malmgren Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Helge Malmgren in
Google Scholar
PubMed Close
,
Peter F Berglund Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Peter F Berglund in
Google Scholar
PubMed Close
,
Birgitta Johansson Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed Close
, and
Helena Filipsson Nyström Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Gothenburg Centre for Person Centred-Care (GPCC), Göteborg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed Close

mental symptoms may be a consequence of the elevated thyroid hormones, the autoimmune reaction, the circumstance that persons with psychiatric conditions may be more prone to develop Graves’ disease (GD), the development of complications like thyroid

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0247
Volume/Issue:
Volume 13: Issue 1
Open access
Claudio Marcocci Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed Close
,
Marenza Leo Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy

Search for other papers by Marenza Leo in
Google Scholar
PubMed Close
, and
Maria Antonietta Altea Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy

Search for other papers by Maria Antonietta Altea in
Google Scholar
PubMed Close

, elevated intracellular ATP consumption, and increased ROS production [ 5 , 6 ]. Moreover, there is evidence supporting a role of oxidative processes in the genesis of Graves’ disease (GD) [ 7 ], hyperthyroidism-induced damage such as thyrotoxic myopathy and

Article Type:
Review Article
DOI:
https://doi.org/10.1159/000337976
Volume/Issue:
Volume 1: Issue 2
Free access
Hiroki Kobayashi Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Hiroki Kobayashi in
Google Scholar
PubMed Close
,
Akira Haketa Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Akira Haketa in
Google Scholar
PubMed Close
,
Masanori Abe Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Masanori Abe in
Google Scholar
PubMed Close
,
Kazunobu Tahira Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Kazunobu Tahira in
Google Scholar
PubMed Close
,
Yoshinari Hatanaka Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Yoshinari Hatanaka in
Google Scholar
PubMed Close
,
Sho Tanaka Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Sho Tanaka in
Google Scholar
PubMed Close
,
Takahiro Ueno Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Takahiro Ueno in
Google Scholar
PubMed Close
, and
Masayoshi Soma Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan

Search for other papers by Masayoshi Soma in
Google Scholar
PubMed Close

thyrotoxicosis [ 4 ]. However, some reports have demonstrated other causes of VF [ 5 , 6 ]. We report here a case of Graves' disease with VF as the result of thyrotoxicosis and review the literature on VF associated with thyrotoxicosis. This case suggests that

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000437225
Volume/Issue:
Volume 4: Issue 3
Free access
Shi Hui Junice Wong Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore

Search for other papers by Shi Hui Junice Wong in
Google Scholar
PubMed Close

Established Facts Radioiodine (RAI) therapy for Graves’ disease is generally well tolerated. RAI therapy can rarely cause radiation-induced thyroiditis, but this is self-limiting and localized to the thyroid gland. Novel

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000503457
Volume/Issue:
Volume 8: Issue 6
Free access
Kira Bang Bové Department of Endocrinology, Odense, Denmark

Search for other papers by Kira Bang Bové in
Google Scholar
PubMed Close
,
Torquil Watt Department of Endocrinology, Odense, Denmark
Institute of Public Health, University of Copenhagen, Odense, Denmark

Search for other papers by Torquil Watt in
Google Scholar
PubMed Close
,
Asmus Vogel Memory Disorders Research Group, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Odense, Denmark

Search for other papers by Asmus Vogel in
Google Scholar
PubMed Close
,
Laszlo Hegedüs Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed Close
,
Jakob Bue Bjoerner Institute of Public Health, University of Copenhagen, Odense, Denmark
National Research Centre for the Working Environment, Copenhagen, Odense, Denmark

Search for other papers by Jakob Bue Bjoerner in
Google Scholar
PubMed Close
,
Mogens Groenvold Institute of Public Health, University of Copenhagen, Odense, Denmark
Department of Palliative Medicine, Bispebjerg Hospital, Odense, Denmark

Search for other papers by Mogens Groenvold in
Google Scholar
PubMed Close
,
Steen Joop Bonnema Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Steen Joop Bonnema in
Google Scholar
PubMed Close
,
Åse Krogh Rasmussen Department of Endocrinology, Odense, Denmark

Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed Close
, and
Ulla Feldt-Rasmussen Department of Endocrinology, Odense, Denmark

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed Close

depression [ 2 , 3 , 4 , 5 , 6 ] but increased prevalence of anxiety and depression is also found in hyperthyroidism [ 7 ], particularly in the early phase of Graves' disease [ 8 , 9 , 10 , 11 ], compared with the general population or compared with patients

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000365211
Volume/Issue:
Volume 3: Issue 3
Free access
N. Papanikolaou Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK

Search for other papers by N. Papanikolaou in
Google Scholar
PubMed Close
and
P. Perros Department of Endocrinology, Royal Victoria Infirmary, Newcastle upon Tyne, UK

Search for other papers by P. Perros in
Google Scholar
PubMed Close

thyrotoxicosis and resolves rapidly after euthyroidism is restored. • Awareness of this very rare manifestation of thyrotoxicosis may obviate the need to seek alternative diagnoses. Introduction Graves’ disease is the commonest cause of thyrotoxicosis

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000343826
Volume/Issue:
Volume 1: Issue 4
Free access
Marta Nascimento Soares Faculty of Medicine of the University of Porto, Porto, Portugal

Search for other papers by Marta Nascimento Soares in
Google Scholar
PubMed Close
,
Marta Borges-Canha Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by Marta Borges-Canha in
Google Scholar
PubMed Close
,
Celestino Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Celestino Neves in
Google Scholar
PubMed Close
,
João Sérgio Neves Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Department of Surgery and Physiology, Cardiovascular Research Unit, Faculty of Medicine from the University of Porto, Porto, Portugal

Search for other papers by João Sérgio Neves in
Google Scholar
PubMed Close
, and
Davide Carvalho Faculty of Medicine of the University of Porto, Porto, Portugal
Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar Universitário de São João, Porto, Portugal
Institute for Research Innovation in Health, University of Porto, Porto, Portugal

Search for other papers by Davide Carvalho in
Google Scholar
PubMed Close

Introduction Graves' disease is an autoimmune thyroid disease, being the most frequent cause of hyperthyroidism ( 1 ). It is caused by the production of autoantibodies (thyrotropin receptor antibodies (TRAbs)) against the thyrotropin receptor

Article Type:
Research Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0055
Volume/Issue:
Volume 12: Issue 4
Open access
Alessandro Brancatella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed Close
,
Nicola Viola Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Nicola Viola in
Google Scholar
PubMed Close
,
Sandra Brogioni Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed Close
,
Lucia Montanelli Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Lucia Montanelli in
Google Scholar
PubMed Close
,
Chiara Sardella Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Chiara Sardella in
Google Scholar
PubMed Close
,
Paolo Vitti Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Paolo Vitti in
Google Scholar
PubMed Close
,
Claudio Marcocci Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed Close
,
Isabella Lupi Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Isabella Lupi in
Google Scholar
PubMed Close
, and
Francesco Latrofa Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed Close

contrary, Graves’ disease has been described in only eight patients during ICPis treatment, five during anti-CTLA-4 and three during anti-PD-1 treatment. We report the fourth case of Grave’s disease induced by anti-PD-1, the second with an overt

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000501824
Volume/Issue:
Volume 8: Issue 4
Free access